03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Dementia
Paresh Malhotra: no photograph is held, so the academic plate is shown instead.
Academic
Paresh Malhotra
Prof, neurologist at Imperial College London and the trial's chief investigator
1
0
0
0
0
0
13
0
Apr 2026MayJuneJulyAugSeptOctNovto date
14
press citations on 1 topic since 20 Apr 2026 · last quoted 29 Oct 2026
02 Quoted on · 1 of 29 topics
Paresh Malhotra: key facts
- Kind of voice
- Academic
- Role
- Prof, neurologist at Imperial College London and the trial's chief investigator
- Quoted on
- Dementia
- Tracked press citations
- 14
- Most recently quoted
- 29 Oct 2026
- First quoted
- 20 Apr 2026
04 The signal · where Paresh Malhotra sits on dementia
Ranked 2= of 100 voices quoted in the press on dementia, level with 1 other on 14 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Lesley PotterClinicianAdmiral Nurse, Dementia UK16
- 2=
Dr Sheona ScalesSector leaderDirector of Research, Alzheimer's Research UK14 - 2=Paresh MalhotraAcademicProf, neurologist at Imperial College London and the trial's chief investigator14
- 4=
Dr Richard OakleySector leaderAssociate Director of Research and Innovation, Alzheimer's Society13 - 4=
Dr. Josef CoreshAcademicFounding Director, Optimal Aging Institute; Terry and Mel Karmazin Professor of Population Health; Professor of Medicine, NYU Grossman School of Medicine / NYU Langone Health13 - 6Dr Jacqui HanleySector leaderHead of Research Funding, Alzheimer's Research UK11
Showing ranks 1 to 6 of 100 voices · See every voice on the topic →
05 On the record · press
What Paresh Malhotra has said
By outlet · linked articles
- aol.co.uk2
- pulsetoday.co.uk2
- bbc.co.uk1
- birminghammail.co.uk1
- cambridgeindependent.co.uk1
Where Paresh Malhotra has been quoted
- 01First Cambridgeshire residents join Alzheimer's study testing existing type 2 diabetes and ADHD drugscambridgeindependent.co.uk · 29 Oct 2026
- 02Researchers Are Trying ADHD Meds On Dementia Patients. Here's Whyhuffingtonpost.co.uk · 23 Oct 2026
- 03New clinical trial backed by Andy Burnham could speed up Alzheimer’s treatments – Care Appointmentscareappointments.com · 22 Oct 2026
- 04Andy Burnham issues NHS ADHD, diabetes, Alzheimer's update for his premiershipbirminghammail.co.uk · 22 Oct 2026
- 05ADHD drug to be tested as Alzheimer’s treatmenttelegraph.co.uk · 22 Oct 2026
- 06Alzheimer’s trial launches to test diabetes and ADHD drugspulsetoday.co.uk · 22 Oct 2026
- 07NHS diabetes & ADHD drugs could be cure to treating Alzheimer's, scientists hopethesun.co.uk · 22 Oct 2026
- 08Pioneering dementia trial will test diabetes and ADHD medicines against Alzheimer's - AOLaol.co.uk · 22 Oct 2026
- 09Pioneering dementia trial will test diabetes and ADHD medicinesexpress.co.uk · 22 Oct 2026
- 10ADHD and diabetes drugs to be used in clinical trial for Alzheimer's patientsitv.com · 22 Oct 2026
- 11Andy Burnham welcomes world-first dementia drug trial after dad Roy dies from the disease - AOLaol.co.uk · 21 Oct 2026
- 12Andy Burnham welcomes world-first dementia trial after dad's deathmirror.co.uk · 21 Oct 2026
- 13Diabetes and ADHD drugs to be tested on Alzheimer's patients in new studybbc.co.uk · 21 Oct 2026
- 14Cochrane review: No ‘meaningful difference’ with anti-amyloid Alzheimer’s drugs - Pulse Todaypulsetoday.co.uk · 20 Apr 2026
Verbatim
“For too long, Alzheimer's research has moved at the pace of one drug, one trial, one answer, sometimes taking a decade or more before we know if we've found something that works.”
“For too long, Alzheimer's research has moved at the pace of one drug, one trial, one answer - sometimes taking a decade or more before we know if we've found something that works”
“For too long, Alzheimer’s research has moved at the pace of one drug, one trial, one answer, sometimes taking a decade or more before we know if we’ve found something that works.”
“What we don't have is a meaningful effect for patients in a big group.”
“What we don’t have is a meaningful effect for patients in a big group.”
“For too long, Alzheimer's research has moved at the pace of one drug, one trial, one answer, sometimes taking a decade or more before we know if we've found something that works.”
“We are applying advances from cancer and other conditions to accelerate testing of treatments for people with Alzheimer's disease.”
“we just are not testing the most promising treatments for Alzheimer's disease quickly enough, and we are not getting enough people with clinical Alzheimer's disease into trials”
“we just are not testing the most promising treatments for Alzheimer's disease quickly enough, and we are not getting enough people with clinical Alzheimer's disease into trials”
“We know there are different processes that drive neurodegeneration, that drive deterioration, and so if we can compare and contrast different treatments that affect different processes, then we should find an effective treatment faster.”
“For too long, Alzheimer's research has moved at the pace of one drug, one trial, one answer - sometimes taking a decade or more before we know if we've found something that works.”
“For too long, Alzheimer's research has moved at the pace of one drug, one trial, one answer - sometimes taking a decade or more before we know if we've found something that works.”
“For too long, Alzheimer's research has moved at the pace of one drug, one trial, one answer - sometimes taking a decade or more before we know if we've found something that works”
“The results of ongoing amyloid-targeting trials will help us understand these treatments better, and we should continue to explore all promising avenues for the treatment of Alzheimer's and other dementia-causing diseases.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Worcestershire hero appears on billboard in 'most famous place in the world'kidderminstershuttle.co.uk
- Rare <i>APOE</i> Mutation Could Be Used To Counter Parkinson's Pathologytechnologynetworks.com
- Could a Nasal Spray Stop Alzheimer’s Before Memory Loss Begins?SciTechDaily
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.